{"id":35529,"date":"2020-06-08T00:00:00","date_gmt":"2020-06-08T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2020\/06\/08\/partnership-would-bypass-drug-industry-to-sell-covid-19-vaccine\/"},"modified":"2020-06-09T16:10:08","modified_gmt":"2020-06-09T16:10:08","slug":"partnership-would-bypass-drug-industry-to-sell-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2020\/06\/08\/partnership-would-bypass-drug-industry-to-sell-covid-19-vaccine\/","title":{"rendered":"Partnership Would Bypass Drug Industry to Sell COVID-19 Vaccine"},"content":{"rendered":"<h3>Vaccine could be sold without profits or licensing fees in Britain and low- and middle-income countries<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>MONDAY, June 8, 2020 (HealthDay News) &#8212; A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed by a laboratory at Imperial College London.<\/p>\n<p>The move would mean the vaccine could be sold without profits or licensing fees in Britain and in low- and middle-income countries, <i>The New York Times<\/i> reported. To be successful, a vaccine against the new coronavirus would have to be available at the lowest possible price and according to need rather than profit.<\/p>\n<p>The Imperial College London lab has technology that may enable it to create a vaccine that is cheaper and easier to produce than others, said project lead scientist Robin Shattock, <i>The Times<\/i> reported.<\/p>\n<p>Clinical trials of the vaccine are scheduled to start this month. If it proves safe and effective, the vaccine could become available early next year.<\/p>\n<p><a href=\"https:\/\/www.nytimes.com\/2020\/06\/07\/world\/europe\/imperial-college-uk-vaccine-coronavirus.html\" target=\"_new\" rel=\"noopener noreferrer\"><i>The New York Times<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vaccine could be sold without profits or licensing fees in Britain and low- and middle-income countries<\/p>\n","protected":false},"author":6,"featured_media":35546,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-35529","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/35529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=35529"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/35529\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/35546"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=35529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=35529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=35529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}